U.S. markets closed
  • S&P 500

    4,179.76
    +60.55 (+1.47%)
     
  • Dow 30

    34,053.94
    -39.02 (-0.11%)
     
  • Nasdaq

    12,200.82
    +384.50 (+3.25%)
     
  • Russell 2000

    2,001.22
    +40.41 (+2.06%)
     
  • Crude Oil

    76.00
    -0.41 (-0.54%)
     
  • Gold

    1,927.10
    -15.70 (-0.81%)
     
  • Silver

    23.55
    -0.06 (-0.27%)
     
  • EUR/USD

    1.0916
    -0.0078 (-0.71%)
     
  • 10-Yr Bond

    3.3960
    -0.0010 (-0.03%)
     
  • GBP/USD

    1.2228
    -0.0144 (-1.16%)
     
  • USD/JPY

    128.6700
    -0.2550 (-0.20%)
     
  • BTC-USD

    23,506.45
    -235.62 (-0.99%)
     
  • CMC Crypto 200

    541.21
    -4.11 (-0.75%)
     
  • FTSE 100

    7,820.16
    +59.05 (+0.76%)
     
  • Nikkei 225

    27,402.05
    +55.17 (+0.20%)
     

Better Dividend Stock: AbbVie or Viatris?

Better Dividend Stock: AbbVie or Viatris?

AbbVie (NYSE: ABBV) and Viatris (NASDAQ: VTRS) have a lot more in common than first glances would suggest. The two were both spun off from larger companies and now deliver above-average dividend yields. In AbbVie's case, it is the patent cliff next year for its immunology drug Humira, the top-selling drug last year other than COVID-19 vaccines.